AMHERST The Manning Family Foundation has gifted the University of Massachusetts Amherst $3 million spanning the next three years through the Manning Innovation Program, which has allowed past recipients to progress in their scientific research and.
AMHERST A treatment to suppress inflammatory bowel disease and technology to deliver probiotics in gummy form are among intellectual property developed in University of Massachusetts laboratories that are promoting human health and well-being.
AMHERST A treatment to suppress inflammatory bowel disease and technology to deliver probiotics in gummy form are among intellectual property developed in University of Massachusetts laboratories that are promoting human health and well-being.
Alumnus Paul Manning ’77 and his wife, Diane, have committed $3 million through their family foundation to expand the Manning Innovation Program at the University of Massachusetts Amherst. The gift provides three years of support in advancing a robust and sustainable commercialization pipeline of applied and translational research projects from the university.
Researchers at UMass Amherst recently unveiled their discovery of a new process for making RNA. The resulting RNA is purer, more copious and likely to be more cost-effective than any previous process could manage.